Study Suggests Smokers Switching to E-cigarettes Reduce Heart Disease Risk

Dec.04.2022
Study Suggests Smokers Switching to E-cigarettes Reduce Heart Disease Risk
A new study published in Circulation found that switching to e-cigarettes can lower the risk of heart disease by 34%.

A recent study published in Circulation suggests that switching to e-cigarettes can reduce the risk of developing heart disease by 34% among smokers.


A foreign research team has analyzed data from 32,000 adult tobacco users who participated in the nationally representative Population Assessment of Tobacco and Health (PATH) from 2013 to 2019. The researchers evaluated e-cigarette and smoking patterns and compared them to disease reports and heart disease incidence, including stroke, heart attacks, and heart failure.


According to the data, smokers have a 1.8 times higher risk of developing heart disease compared to non-smokers, while there is no statistically significant difference in the risk for heart disease between e-cigarette users and non-users. The study concludes that there is a significant link between smoking and heart disease, but no significant link between e-cigarettes and heart disease.


On the other hand, a recent study entitled "Tobacco Use Disorders and Cardiovascular Health" found that the use of combustible tobacco products, smokeless tobacco, and nicotine-containing electronic cigarettes all increase the incidence of acute and chronic cardiovascular diseases. The researchers also added that these harmful effects can be relatively quickly reduced after quitting smoking.


As a result, the research team recommends more traditional methods for quitting smoking, such as providing medication treatment, emphasizing counseling for rapidly reducing risk after quitting, and appropriate follow-up.


A study utilizing data collected from 175,000 individuals who participated in the annual national health interview survey between 2014 and 2019 has found that daily use of e-cigarettes is only associated with higher rates of heart attacks among those who also regularly smoke traditional cigarettes. Additionally, no evidence was found to suggest that individuals who exclusively use e-cigarettes and have never smoked traditional cigarettes are at risk for heart attacks.


2FIRSTS will continue to report on this issue, with further updates available on the '2FIRSTS APP'. Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
Tamarind Intelligence’s decision to appoint a technology-sector executive as chief executive officer signals more than a leadership reshuffle at a specialist data firm. It reflects a broader structural shift across the global nicotine industry, where companies, regulators and intelligence providers are embedding artificial intelligence into core operations.
Special Report
Feb.18
Indonesia’s vape retailers adopt 21+ signage and ID verification requirements, report says
Indonesia’s vape retailers adopt 21+ signage and ID verification requirements, report says
RetailNews Asia reported that the Association of Indonesian Vape Retailers (Arvindo) has directed member stores to stop selling e-cigarettes to people under 21 and to display 21+ signage and verify customer age using valid identification.
Feb.27
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11
BlackRock Enters Top Shareholder Ranks as KT&G Holding Reaches 5.01%
BlackRock Enters Top Shareholder Ranks as KT&G Holding Reaches 5.01%
BlackRock increased its stake in KT&G to 5.01% after purchasing 68,646 shares, bringing total holdings to 5,914,169 shares and triggering Korea’s large-shareholding disclosure rules. KT&G shares climbed to an all-time intraday high of 153,900(about US$106.19) won and closed at a record 152,900(about US$105.50) won. KT&G is set to report earnings on Feb. 5, with consensus pointing to year-on-year growth in revenue and operating profit.
Jan.30 by 2FIRSTS.ai
Milton Police Call It Florida’s Largest Illegal Vape Seizure, With 500+ Products Confiscated Across Seven Stores
Milton Police Call It Florida’s Largest Illegal Vape Seizure, With 500+ Products Confiscated Across Seven Stores
According to a Milton Police Department (MPD) news release, Milton, Florida officers and partner agencies carried out compliance checks at seven vape retailers on Jan. 27, seizing more than 500 illegal vape products and arresting employees allegedly involved in sales to minors. Authorities also reported finding unlicensed marijuana sales, high-THC products, nitrous oxide and illegal charging units.
Jan.29 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11